274 related articles for article (PubMed ID: 16246972)
1. Hydrolysis of angiotensin peptides by human angiotensin I-converting enzyme and the resensitization of B2 kinin receptors.
Chen Z; Tan F; Erdös EG; Deddish PA
Hypertension; 2005 Dec; 46(6):1368-73. PubMed ID: 16246972
[TBL] [Abstract][Full Text] [Related]
2. N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE.
Deddish PA; Marcic B; Jackman HL; Wang HZ; Skidgel RA; Erdös EG
Hypertension; 1998 Apr; 31(4):912-7. PubMed ID: 9535414
[TBL] [Abstract][Full Text] [Related]
3. Human ACE and bradykinin B2 receptors form a complex at the plasma membrane.
Chen Z; Deddish PA; Minshall RD; Becker RP; Erdös EG; Tan F
FASEB J; 2006 Nov; 20(13):2261-70. PubMed ID: 17077303
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of bradykinin and resensitization of its B2 receptor.
Marcic B; Deddish PA; Jackman HL; Erdös EG
Hypertension; 1999 Mar; 33(3):835-43. PubMed ID: 10082496
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism.
Rice GI; Thomas DA; Grant PJ; Turner AJ; Hooper NM
Biochem J; 2004 Oct; 383(Pt 1):45-51. PubMed ID: 15283675
[TBL] [Abstract][Full Text] [Related]
6. Products of angiotensin I hydrolysis by human cardiac enzymes potentiate bradykinin.
Erdös EG; Jackman HL; Brovkovych V; Tan F; Deddish PA
J Mol Cell Cardiol; 2002 Dec; 34(12):1569-76. PubMed ID: 12505055
[TBL] [Abstract][Full Text] [Related]
7. ACE activity is modulated by kinin B2 receptor.
Sabatini RA; Guimarães PB; Fernandes L; Reis FC; Bersanetti PA; Mori MA; Navarro A; Hilzendeger AM; Santos EL; Andrade MC; Chagas JR; Pesquero JL; Casarini DE; Bader M; Carmona AK; Pesquero JB
Hypertension; 2008 Mar; 51(3):689-95. PubMed ID: 18212275
[TBL] [Abstract][Full Text] [Related]
8. Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade.
Tom B; de Vries R; Saxena PR; Danser AH
Hypertension; 2001 Jul; 38(1):95-9. PubMed ID: 11463767
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of the actions of bradykinin by angiotensin I-converting enzyme inhibitors. The role of expressed human bradykinin B2 receptors and angiotensin I-converting enzyme in CHO cells.
Minshall RD; Tan F; Nakamura F; Rabito SF; Becker RP; Marcic B; Erdös EG
Circ Res; 1997 Nov; 81(5):848-56. PubMed ID: 9351459
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C and phosphatase inhibitors block the ability of angiotensin I-converting enzyme inhibitors to resensitize the receptor to bradykinin without altering the primary effects of bradykinin.
Marcic BM; Erdös EG
J Pharmacol Exp Ther; 2000 Aug; 294(2):605-12. PubMed ID: 10900238
[TBL] [Abstract][Full Text] [Related]
11. Replacement of the transmembrane anchor in angiotensin I-converting enzyme (ACE) with a glycosylphosphatidylinositol tail affects activation of the B2 bradykinin receptor by ACE inhibitors.
Marcic B; Deddish PA; Skidgel RA; Erdös EG; Minshall RD; Tan F
J Biol Chem; 2000 May; 275(21):16110-8. PubMed ID: 10748135
[TBL] [Abstract][Full Text] [Related]
12. Kinins, receptors, kininases and inhibitors--where did they lead us?
Erdös EG; Marcic BM
Biol Chem; 2001 Jan; 382(1):43-7. PubMed ID: 11258670
[TBL] [Abstract][Full Text] [Related]
13. [ACE inhibitors--activators of kinin receptors].
Kugaevskaia EV; Eliseeva IuE
Biomed Khim; 2011; 57(3):282-99. PubMed ID: 21863742
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I.
Greco AJ; Master RG; Fokin A; Baber SR; Kadowitz PJ
Can J Physiol Pharmacol; 2006 Nov; 84(11):1163-75. PubMed ID: 17218981
[TBL] [Abstract][Full Text] [Related]
15. Kallikrein activates bradykinin B2 receptors in absence of kininogen.
Biyashev D; Tan F; Chen Z; Zhang K; Deddish PA; Erdös EG; Hecquet C
Am J Physiol Heart Circ Physiol; 2006 Mar; 290(3):H1244-50. PubMed ID: 16272198
[TBL] [Abstract][Full Text] [Related]
16. Neprilysin inhibitors potentiate effects of bradykinin on b2 receptor.
Deddish PA; Marcic BM; Tan F; Jackman HL; Chen Z; Erdös EG
Hypertension; 2002 Feb; 39(2 Pt 2):619-23. PubMed ID: 11882619
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin 1-9 and 1-7 release in human heart: role of cathepsin A.
Jackman HL; Massad MG; Sekosan M; Tan F; Brovkovych V; Marcic BM; Erdös EG
Hypertension; 2002 May; 39(5):976-81. PubMed ID: 12019279
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin 1-7 induces bradykinin-mediated relaxation in porcine coronary artery.
Gorelik G; Carbini LA; Scicli AG
J Pharmacol Exp Ther; 1998 Jul; 286(1):403-10. PubMed ID: 9655885
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II binding to angiotensin I-converting enzyme triggers calcium signaling.
Guimarães PB; Alvarenga ÉC; Siqueira PD; Paredes-Gamero EJ; Sabatini RA; Morais RL; Reis RI; Santos EL; Teixeira LG; Casarini DE; Martin RP; Shimuta SI; Carmona AK; Nakaie CR; Jasiulionis MG; Ferreira AT; Pesquero JL; Oliveira SM; Bader M; Costa-Neto CM; Pesquero JB
Hypertension; 2011 May; 57(5):965-72. PubMed ID: 21422380
[TBL] [Abstract][Full Text] [Related]
20. Effects of the N-terminal sequence of ACE on the properties of its C-domain.
Marcic B; Deddish PA; Jackman HL; Erdös EG; Tan F
Hypertension; 2000 Jul; 36(1):116-21. PubMed ID: 10904022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
